MONDAY, June 23, 2025 (HealthDay News) — For patients with heart failure, hospital participation in the IMPLEMENT-HF initiative improves adherence to quadruple medication therapy (QMT), defined as an evidence based β-blocker, sodium-glucose cotransporter 2 inhibitor, angiotensin receptor/neprilysin inhibitor, and mineralocorticoid receptor antagonist, according to a study published online March 21 in Circulation: Heart Failure. Andrew […]
The post Quality Improvement Initiative Ups Adherence to Medical Therapy for Heart Failure first appeared on Physician’s Weekly.
